Extract of Hypericum perforatum blocks caffeine-induced locomotor activity in mice: A possible role of nitric oxide

Phytotherapy Research

Volumn 21, Issue 5, 2007, Pages 415-419

  Uzbay, I Tayfun ^a   Coskun, Ilke ^b   Kayir, Hakan ^a   Ozturk, Nilgun ^b   Ozturk, Yusuf ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ANADOLU UNIVERSITY   (Turkey)

Author keywords

Caffeine; Hypericum perforatum; Locomotor activity; Mice; Nitric oxide; St John's wort

Indexed keywords

ARGININE; CAFFEINE; HYPERICUM PERFORATUM EXTRACT; NITRIC OXIDE; PLANT EXTRACT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NONHUMAN;

ANIMALS; ARGININE; CAFFEINE; HYPERICUM; MALE; MICE; MOTOR ACTIVITY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLANT EXTRACTS;

HYPERICUM PERFORATUM; MUS;

EID: 34248174537     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2085     Document Type: Article

References (45)

1. Arold G, Donath F, Maurer A et al. 2005. No relevant interaction with alprozalam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's extract. Planta Med 71: 331-337.
2. Bredt DS, Snyder SH. 1992. Nitric oxide, a novel neuronal messenger. Neuron 8: 3-11.
3. Bruhwyler J, Chleide E, Liégeois JF, Carreer F. 1993. Nitric oxide: a new messenger in the brain. Neurosci Biobehav Rev 17: 373-384.
4. Buisson A, Lakhmecce N, Verrechia C, Plotkine M, Boulu RG. 1993. Nitric oxide: an endogenous anticonvulsant substance. Neuroreport 4: 444-446.
5. Butterweck V, Christoffel V, Nahrstedt A, Peterit F, Spengler B, Winterhoff H. 2003. Step by step removal of hyperforin and hypericin: Activity profile of different hypericum preparations in behavioral models. Life Sci 73: 627-639.
6. Butterweck V, Petereit F, Winterhoff H, Nahrstedt A. 1998. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Med 64: 291-294.
7. Butterweck V, Wall A, Lieflander-Wulf U, Winterhoff H, Nahrstedt A. 1997. Effects of total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry 30 (Suppl. 2): 117-124.
8. Catania MA, Firenzuoli F, Crupi A, Mannucci C, Caputi AP, Calapai G. 2003. Hypericum perforatum attenuates nicotine withdrawal signs in mice. Psychopharmacology 169: 186-189.
9. Cauli O, Morelli M. 2005. Caffeine and dopaminergic system. Behav Pharmacol 16: 63-77.
10. Celik T, Zagli U, Kayir H, Uzbay IT. 1999. Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice. Drug Alcohol Depend 56: 109-113.
11. Daly JW, Fredholm BB. 1998. Caffeine - an atypical drug of dependence. Drug Alcohol Depend 51: 199-206.
12. Ernst E. 1995. St John's Wort, an antidepressant? A systematic, criteria based review. Phytomedicine 2: 67-71.
13. Fisone G, Borgkvist A, Usiello A. 2004 Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci 61: 857-872.
14. Greeson JM, Sanford B, Monti DA. 2001. St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology 153: 402-414.
15. Hosseinzadeh H, Karimi G-R, Rakhshanizadeh M. 2005. Anticonvulsant effect of Hypericum perforatum: role of nitric oxide. J Ethnopharmacol 98: 207-208.
16. Jelenkovic A, Jovanovic M, Ninkovic M, Bokonjic D, Boskovic B. 2002. Nitric oxide (NO) and convulsions induced by pentylenetetrazol. Ann N Y Acad Sci 962: 296-305.
17. Kaputlu I, Uzbay IT. 1997. L-NAME inhibits pentylenetetrazole and strychinine-induced seizures in mice. Brain Res 753: 98-101.
18. Kasper S, Dienel A. 2002. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology 164: 301-308.
19. Kayir H, Uzbay IT. 2004. Evidence for the role of nitric oxide in caffeine-induced locomotor activity in mice. Psychopharmacology 172: 11-15.
20. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. 1996. St John's wort for depression - an overview and meta-analysis of randomized clinical tirals. Br Med J 313: 253-258.
21. Luo L, Sun Q, Mao YY, Lu YH, Tan RX. 2004. Inhibitory effects of flavonoids from Hypericum perforatum on nitric oxide synthase. J Ethnopharmacol 93: 221-225.
22. Luo L, Tan R-X. 2001. Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model. Acta Pharmacol Sin 22: 865-870.
23. Melchart D. 1996. St John's wort for depression - an overview and meta-analysis of randomized clinical trials. Br Med J 313: 241-242.
24. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 102: 198-202.
25. Muller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schafer C. 1998. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 31 (Suppl. 1): 16-21.
26. Mumford GK, Holtzmann GK. 1991. Qualitative differences in the discrimination stimulus effects of low and high doses of caffeine in the rat. J Pharmacol Exp Ther 258: 857-865.
27. Nikodijevic O, Daly JW, Jacobson KA. 1990. Characterization of the locomotor depression produced by an A2-selective adenosine agonist. FEBS Left 261: 67-70.
28. Osonoe K, Mori N, Suzuki K, Osonoe M. 1994. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res 663: 338-340.
29. Ozturk Y. 1997. Testing the antidepressant effects of hypericum species on animal models. Pharmacopsychiatry 30 (Suppl. 2): 125-128.
30. Ozturk Y, Aydm S, Başer KHC, Kirimer N, Kurtar-Ozturk N. 1992. Hepatoprotective activity of Hypericum perforatum L. alcoholic extract in rodents. Phytother Res 6: 44-46.
31. Ozturk Y, Aydin S, Beis R, Başer KHC, Berberoǧlu H. 1996. Effects of Hypericum perforatum L. and Hypericum calycinum L. extracts on the central nervous system in mice. Phytomedicine 3: 139-146.
32. Perfumi M, Ciccocioppo R, Angeletti S, Cucculelli M, Massi M. 1999. Effects of Hypericum perforatum extract on alcohol intake in Marchigian Sardinian alcohol-preferring rats. Alcohol Alcohol 34: 690-698.
33. Rezvani AH, Overstreet DH, Yang Y, Clark. 1999. Attenuation of alcohol intake by extract of Hypericum perforatum (St John's wort) in two different strains of alcohol-preferring rats. Alcohol Alcohol 34: 669-675.
34. Snyder SH. 1992. Nitric oxide: first in a new class of neurotransmitters. Science 257: 494-496.
35. Ulusu U, Uzbay IT, Kayir H, Alici T, Karakas S. 2005. Evidence for the role of nitric oxide in nicotine-induced sensitization in mice. Psychopharmacology 178: 500-504.
36. Uzbay IT, Coskun I, Ozturk N, Ozturk Y. 2005a. Effects of St John's Wort on ethanol withdrawal syndrome in rats. World J Biol Psychiat 6 (Suppl. 1): 311.
37. Uzbay IT, Kayir H, Coskun I, Ozturk N, Ozturk Y. 2005b. St John's Wort blocks nicotine-induced locomotor activity in mice. World J Biol Psychiat 6 (Suppl. 1): 310.
38. Uzbay IT, Oglesby MW. 2001. Nitric oxide and substance dependence. Neurosci Biobehav Rev 25: 43-52.
39. Volz HP. 1997. Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry 30 (Suppl. 2): 72-76.
40. Wegener G, Volke V, Harvey BH, Rosenberg R. 2003. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res 959: 128-134.
41. Wise RA, Bozarth MA. 1987. A psychomotor stimulant theory of addiction. Psychol Rev 94: 469-497.
42. Yamada K, Noda Y, Nakayama S et al. 1995. Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br J Pharmacol 115: 852-858.
43. Yaron I, Shirazi I, Judovich R, Levartovsky D, Caspi D, Yaron M. 1999. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum 42: 2561-2568.
44. Yildiz F, Erden BF, Ulak G, Utkan T, Gacar N. 2000a. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology 149: 41-44.
45. Yildiz F, Ulak G, Erden BF, Gacar N. 2000b. Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test. Pharmacol Biochem Behav 65: 199-202.